French Perfume Brand Ex Nihilo Receives 25 Million Euros Investment from Eurazeo
Niche fragrance brand Ex Nihilo has received a €25 million investment from Paris-based investor Eurazeo to grow its business.
Through the transaction, Eurazeo acquires a minority stake in the French fragrance company and will use its expertise to support Ex Nihilo's expansion into new markets, as well as strengthen its digital capabilities and grow its community.
Ex Nihilo, which means "created out of nothing" in Latin, was founded in 2013 by Sylvie Loday, Olivier Royère and Benoît Verdier to offer a range of fragrances focused on unique ingredients and personalization. Best known for its floral Fleur Narcotique fragrance, other fragrances in its portfolio include Lust in Paradise and My Sweetest Morphine.
The brand is currently sold through retail partners including Harrods, Bergdorf Goodman, Galeries Lafayette and Saks Fifth Avenue, as well as through its own seven flagship stores.
"The partnership between Ex Nihilo and Eurazeo is an organic one, rooted in shared values and a common vision for the future. We recognize Eurazeo's strong commitment to fostering growth and innovation, which aligns perfectly with Ex Nihilo’s commitment to pushing the boundaries of luxury fragrance. " said Loday, Royère and Verdier.
"Our goal is to take the industry to new heights and provide our customers with an unparalleled experience. We are excited about the extraordinary milestones we will achieve together." the co-founders added.
Eurazeo has a long history of investing in beauty brands. The company has previously invested in Pat McGrath Labs, skin care brand Beekman 1802 and honey beauty brand Gisou.
China agrochemical industry weekly(0119)
2026-09-02
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BASF Ludwigshafen Workforce Falls Below 30,000, Lowest Level in 72 Years
-
Bristol Myers Squibb Launches Mavacamten (“Kopozgo”) in India for Obstructive Hypertrophic Cardiomyopathy
-
Ancora Offers Up to $1.2 Billion for H.B. Fuller Building Adhesives Business
-
Bayer’s Ambitious Gene & Cell Therapy Pipeline Eyes Parkinson’s, Oncology, Rare Diseases
-
Braskem Weighs Out-of-Court Restructuring as $10 Billion Debt Burden Deepens Petrochemical Crisis
-
Wanhua Chemical's 240,000-ton/year Iron Phosphate Project Approved
-
Dow Chemical’s Freeport Plant Fire Contained; No Injuries Reported
-
INEOS Plant Closures Deepen Europe’s Chemical Industry Crisis
-
Three-Phase Plan for 120,000 Tons! “TPU King” Zhuhai Makes Its Move—Covestro’s New Plant Signals Not Just Capacity Expansion but a Full-Scale Upgrade in the Asia-Pacific Market Battle
-
India Terminates Anti-Dumping Investigation on Chinese Siloxane Polyoxyalkylene Copolymers
Recommend Reading
-
Pharmaceutical State-Owned Enterprise Acquires Leading Pesticide Company for RMB 5.656 Billion, Betting on Synthetic Biology Industrialization
-
Roche Takes Natco to Supreme Court Over Generic Risdiplam Launch in India
-
Wanhua Chemical Expands TPU Production by 200,000 Tons with RMB 287 Million Investment
-
Azelis Strengthens Partnership with SI Group, Becoming Its New Distributor of Plastic Additives
-
Mitsubishi Chemical to Halt Production of Key Epoxy Resin Grades by 2027
-
Business Society’s August 14, 2026 View on Isooctanol Market Trends: Stagnation and Price Increase Alert
-
Business Society’s August 13, 2026 Xylenol Market Outlook: Continuing to Rise
-
In July, the Chinese anhydrous hydrogen fluoride market showed an upward trend
-
Business Society’s Phosphoric Acid Market Outlook on August 13, 2026: Low-Range Adjustment
-
MTBE Market Trend Shows Significant Decline in China
- Hot Searches
- ampelopsis grossedentata
- polybutylene terephthalate price
- industrial carbon black pigment supplier
- glycerol mono stearate
- polypropylene cost
- pacific chemical
- dichlorormethane
- heat+shrinkable+fluoropolymer+tubing
- ammonia price index
- pp price
- buy nandrolone decanoate
- 1 bromo 4 fluorobenzene